Literature DB >> 9462240

Normal distribution of collagen IV in renal basement membranes in Epstein's syndrome.

I Naito1, S Nomura, S Inoue, M Kagawa, S Kawai, Y Gunshin, K Joh, C Tsukidate, Y Sado, G Osawa.   

Abstract

BACKGROUND: Epstein's syndrome is defined as a subtype of Alport's syndrome, and is distinguished from the other subtypes by accompanying macrothrombocytopenia. Mutations in collagen IV genes are known to be involved in the pathogenesis of typical Alport's syndrome. However, the presence of an underlying genetic defect has not been demonstrated in Epstein's syndrome. AIM: To clarify the involvement of collagen IV in Epstein's syndrome.
METHODS: The distribution of the alpha(IV) chain was studied in renal specimens obtained from three patients with Epstein's syndrome using chain specific monoclonal antibodies and an antigen retrieval procedure.
RESULTS: The patients showed a normal distribution of alpha(IV) chains: alpha 1(IV) and alpha 2(IV) were expressed ubiquitously, whereas expression of alpha 3(IV) through to alpha 6(IV) chains was limited to the glomerular basement membrane, Bowman's capsular basement membrane, and/or a portion of the tubular basement membrane.
CONCLUSIONS: These results suggest that genes other than those encoding alpha(IV) chains are responsible for the pathogenesis of Epstein's syndrome.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9462240      PMCID: PMC500315          DOI: 10.1136/jcp.50.11.919

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  11 in total

1.  Identification of mutations in the COL4A5 collagen gene in Alport syndrome.

Authors:  D F Barker; S L Hostikka; J Zhou; L T Chow; A R Oliphant; S C Gerken; M C Gregory; M H Skolnick; C L Atkin; K Tryggvason
Journal:  Science       Date:  1990-06-08       Impact factor: 47.728

2.  The COL4A5 gene in Japanese Alport syndrome patients: spectrum of mutations of all exons. The Japanese Alport Network.

Authors:  S Kawai; S Nomura; T Harano; K Harano; T Fukushima; G Osawa
Journal:  Kidney Int       Date:  1996-03       Impact factor: 10.612

Review 3.  Molecular properties of the glomerular basement membrane.

Authors:  T Pihlajaniemi
Journal:  Contrib Nephrol       Date:  1996       Impact factor: 1.580

4.  Nephritogenic antigen determinants in epidermal and renal basement membranes of kindreds with Alport-type familial nephritis.

Authors:  C Kashtan; A J Fish; M Kleppel; K Yoshioka; A F Michael
Journal:  J Clin Invest       Date:  1986-10       Impact factor: 14.808

5.  Hereditary macrothrombocytopathia, nephritis and deafness.

Authors:  C J Epstein; M A Sahud; C F Piel; J R Goodman; M R Bernfield; J H Kushner; A R Ablin
Journal:  Am J Med       Date:  1972-03       Impact factor: 4.965

6.  Establishment by the rat lymph node method of epitope-defined monoclonal antibodies recognizing the six different alpha chains of human type IV collagen.

Authors:  Y Sado; M Kagawa; Y Kishiro; K Sugihara; I Naito; J M Seyer; M Sugimoto; T Oohashi; Y Ninomiya
Journal:  Histochem Cell Biol       Date:  1995-10       Impact factor: 4.304

7.  Relationship between COL4A5 gene mutation and distribution of type IV collagen in male X-linked Alport syndrome. Japanese Alport Network.

Authors:  I Naito; S Kawai; S Nomura; Y Sado; G Osawa
Journal:  Kidney Int       Date:  1996-07       Impact factor: 10.612

8.  Identification of mutations in the alpha 3(IV) and alpha 4(IV) collagen genes in autosomal recessive Alport syndrome.

Authors:  T Mochizuki; H H Lemmink; M Mariyama; C Antignac; M C Gubler; Y Pirson; C Verellen-Dumoulin; B Chan; C H Schröder; H J Smeets
Journal:  Nat Genet       Date:  1994-09       Impact factor: 38.330

9.  Mutations in the type IV collagen alpha 3 (COL4A3) gene in autosomal recessive Alport syndrome.

Authors:  H H Lemmink; T Mochizuki; L P van den Heuvel; C H Schröder; A Barrientos; L A Monnens; B A van Oost; H G Brunner; S T Reeders; H J Smeets
Journal:  Hum Mol Genet       Date:  1994-08       Impact factor: 6.150

10.  X-linked Alport syndrome: an SSCP-based mutation survey over all 51 exons of the COL4A5 gene.

Authors:  A Renieri; M Bruttini; L Galli; P Zanelli; T Neri; S Rossetti; A Turco; N Heiskari; J Zhou; R Gusmano; L Massella; G Banfi; F Scolari; A Sessa; G Rizzoni; K Tryggvason; P F Pignatti; M Savi; A Ballabio; M De Marchi
Journal:  Am J Hum Genet       Date:  1996-06       Impact factor: 11.025

View more
  5 in total

1.  Glomerular pathology in autosomal dominant MYH9 spectrum disorders: what are the clues telling us about disease mechanism?

Authors:  Jeffrey B Kopp
Journal:  Kidney Int       Date:  2010-07       Impact factor: 10.612

Review 2.  Hearing loss and renal syndromes.

Authors:  Paul J Phelan; Michelle N Rheault
Journal:  Pediatr Nephrol       Date:  2017-11-12       Impact factor: 3.714

3.  [An epidemiological investigation of chronic kidney disease in children with hearing disorder in Hunan province, China].

Authors:  Xiang-Yang Cheng; Yi-Feng Zhu; Shu Luo; Yan He; Xiang-Chuan Wang
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2019-09

Review 4.  Basement Membrane Defects in Genetic Kidney Diseases.

Authors:  Christine Chew; Rachel Lennon
Journal:  Front Pediatr       Date:  2018-01-29       Impact factor: 3.418

5.  MYH9-related disorders display heterogeneous kidney involvement and outcome.

Authors:  Nahid Tabibzadeh; Dominique Fleury; Delphine Labatut; Frank Bridoux; Arnaud Lionet; Noémie Jourde-Chiche; François Vrtovsnik; Nicole Schlegel; Philippe Vanhille
Journal:  Clin Kidney J       Date:  2018-12-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.